- Highly efficient cash conversion (101% FCF/OCF ratio)
- Trading above its 200-day moving average
- High gross margin of 47.0%
Channel Therapeutics Corporation stock upgraded from Sell Candidate to Buy Candidate after Monday trading session
(Updated on Jul 20, 2026)
The Channel Therapeutics Corporation stock price gained 1.64% on the last trading day (Monday, 20th Jul 2026), rising from $26.82 to $27.26. During the last trading day the stock fluctuated 8.24% from a day low at $26.77 to a day high of $28.98. The price has fallen in 6 of the last 10 days but is still up by 9.57% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 166 thousand more shares were traded than the day before. In total, 176 thousand shares were bought and sold for approximately $4.80 million.
The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 10.77% during the next 3 months and, with a 90% probability hold a price between $27.73 and $33.64 at the end of this 3-month period.
PTHS Signals & Forecast
The Channel Therapeutics Corporation stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $26.60 and $27.12. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, July 07, 2026, and so far it has risen 10.81%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Channel Therapeutics Corporation stock
Channel Therapeutics Corporation finds support from accumulated volume at $27.00 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $2.21 between high and low, or 8.24%. For the last week, the stock has had daily average volatility of 7.94%.
Our recommended stop-loss: $26.16 (-4.02%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 9 days ago.)
Trading Expectations (PTHS) For The Upcoming Trading Day Of Tuesday 21st
For the upcoming trading day on Tuesday, 21st we expect Channel Therapeutics Corporation to open at $27.67, and during the day (based on 14 day Average True Range), to move between $26.38 and $28.14, which gives a possible trading interval of +/-$1.76 (+/-6.69%) up or down from last closing price. If Channel Therapeutics Corporation takes out the full calculated possible swing range there will be an estimated 6.69% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $27.00 (0.95%) than the resistance at $27.69 (1.58%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Channel Therapeutics Corporation stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Channel Therapeutics Corporation stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.
Current score:
3.157
Buy Candidate
Upgraded
Predicted Fair Opening Price
Predicted fair opening price on July 21, 2026 - $27.67 ( 1.50%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
PTHS Performance
Trading levels for PTHS
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 29.87 | 9.59% |
| R2 | 29.03 | 6.50% |
| R1 | 28.51 | 4.59% |
| Price | 27.26 | |
| S1 | 26.83 | -1.59% |
| S2 | 26.31 | -3.50% |
| S3 | 25.46 | -6.59% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 28.26 | 3.67% |
| R2 | 28.00 | 2.71% |
| R1 | 27.69 | 1.58% |
| Price | 27.26 | |
| S1 | 27.00 | -0.95% |
| S2 | 26.87 | -1.43% |
| S3 | 26.50 | -2.79% |
FAQ
Click here for our free guide on how to buy Channel Therapeutics Corporation Stock.
Buy PTHS